ID: ALA3344364

Max Phase: Preclinical

Molecular Formula: C34H50ClN7O6

Molecular Weight: 688.27

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)OCc1ccccc1)[C@@H](O)CC(=O)N(C)CCc1ccc(Cl)cc1

Standard InChI:  InChI=1S/C34H50ClN7O6/c1-22(2)19-28(29(43)20-30(44)42(4)18-16-24-12-14-26(35)15-13-24)40-31(45)23(3)39-32(46)27(11-8-17-38-33(36)37)41-34(47)48-21-25-9-6-5-7-10-25/h5-7,9-10,12-15,22-23,27-29,43H,8,11,16-21H2,1-4H3,(H,39,46)(H,40,45)(H,41,47)(H4,36,37,38)/t23-,27-,28-,29-/m0/s1

Standard InChI Key:  DNZNBEZRKTXBCA-HPEBZSCQSA-N

Associated Targets(Human)

HepG2 196354 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serum 1292 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasmepsin V 114 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Plasmodium falciparum 966862 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 688.27Molecular Weight (Monoisotopic): 687.3511AlogP: 2.69#Rotatable Bonds: 19
Polar Surface Area: 198.97Molecular Species: BASEHBA: 7HBD: 7
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.48CX Basic pKa: 11.85CX LogP: 2.24CX LogD: 0.15
Aromatic Rings: 2Heavy Atoms: 48QED Weighted: 0.07Np Likeness Score: -0.17

References

1. Sleebs BE, Gazdik M, O'Neill MT, Rajasekaran P, Lopaticki S, Lackovic K, Lowes K, Smith BJ, Cowman AF, Boddey JA..  (2014)  Transition state mimetics of the Plasmodium export element are potent inhibitors of Plasmepsin V from P. falciparum and P. vivax.,  57  (18): [PMID:25167370] [10.1021/jm500797g]
2. Gazdik M, O'Neill MT, Lopaticki S, Lowes KN, Smith BJ, Cowman AF, Boddey JA, Sleebs BE.  (2015)  The effect of N-methylation on transition state mimetic inhibitors of the Plasmodium protease, plasmepsin V,  (3): [10.1039/C4MD00409D]

Source